about
Terminal Interface Conformations Modulate Dimer Stability Prior to Amino Terminal Autoprocessing of HIV-1 ProteaseButelase 1 is an Asx-specific ligase enabling peptide macrocyclization and synthesisChanging the topology of protein backbone: the effect of backbone cyclization on the structure and dynamics of a SH3 domain.At the Interface of Chemical and Biological Synthesis: An Expanded Genetic Code.Biological synthesis of circular polypeptidesDiscovery and characterization of a novel cyclic peptide that effectively inhibits ephrin binding to the EphA4 receptor and displays anti-angiogenesis activityIntein applications: from protein purification and labeling to metabolic control methods.Ribosomal route to small-molecule diversityDiscovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2.Genetically encoded libraries of nonstandard peptides.Codon randomization for rapid exploration of chemical space in thiopeptide antibiotic variants.Recombinant expression of backbone-cyclized polypeptides.Evolution of iron(II)-finger peptides by using a bipyridyl amino acid.Peptides come round: using SICLOPPS libraries for early stage drug discovery.Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino AcidsExploring the potential impact of an expanded genetic code on protein functionRecombinant Expression and Phenotypic Screening of a Bioactive Cyclotide Against α-Synuclein-Induced Cytotoxicity in Baker's Yeast.Discovering functional, non-proteinogenic amino acid containing, peptides using genetic code reprogramming.Shifting Native Chemical Ligation into Reverse through N→S Acyl Transfer.Enhancing protein stability with extended disulfide bonds.Ribosomal Synthesis of Natural-Product-Like Bicyclic Peptides in Escherichia coli.Recombinant thiopeptides containing noncanonical amino acids.Chemical and biological production of cyclotides.Split Inteins: Nature's Protein Ligases.Expression of fluorescent cyclotides using protein trans-splicing for easy monitoring of cyclotide-protein interactions.Synthetase polyspecificity as a tool to modulate protein function.Inteins: Nature's Gift to Protein Chemists.Photo-induced covalent cross-linking for the analysis of biomolecular interactions.Therapeutic applications of an expanded genetic code.New Modalities for Challenging Targets in Drug Discovery.Analysis of amyloid nanostructures using photo-cross-linking: in situ comparison of three widely used photo-cross-linkers.A promiscuous split intein with expanded protein engineering applications.Directing Biosynthesis: Practical Supply of Natural and Unnatural Cyanobactins.Exploring the Energy Landscapes of Cyclic Tetrapeptides with Discrete Path Sampling.Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.Bioinspired strategy for the ribosomal synthesis of thioether-bridged macrocyclic peptides in bacteria.Programmable Bio-surfaces for Biomedical Applications.Directing evolution: the next revolution in drug discovery?Playing with the molecules of life.Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids.
P2860
Q27676717-9A8F54A6-EC16-4167-9779-BEBF83D0F7A6Q28244237-CD2F82FE-EAC3-427A-AE8F-B6580D7508C3Q30009183-3862ADA5-E8DE-4FD0-B865-EE8B6F98B2E3Q30390524-5F286286-0C75-4026-A55F-8722C31AF3B2Q30418154-5BEBB774-FA2C-419B-89D7-82DCD7BBF09DQ31144324-C05DF209-C99F-44C1-95AD-BE6ECFE02118Q33652036-56CBF8B7-658B-4065-8482-839ED6AD4F67Q34080175-900A68A9-2E18-42D4-A3B0-A189BC769FA4Q34177958-F5C4860D-4FD7-46F5-92AD-792B71A028E6Q34457705-936F647E-A2F3-4BCB-85B4-73047E0794EBQ34520644-59784DDC-3B32-4D9A-867A-69678FD61574Q34871830-FEC9E016-2332-495F-B027-A913DB7E9E8AQ35109870-EB914291-6ECA-4F5B-B7EF-0F2C41ABC39FQ35209857-F804169A-75D7-4774-AAEC-FC33553CF2EDQ35620228-02EF44AD-5702-4271-90FE-80003043CF85Q35650693-ECA928F3-F33C-4773-807E-C216C65C61A5Q35670095-D7B5E209-3314-4E17-833A-D8F423F22309Q35747679-DAE56B0B-0B21-44D7-BD9F-658061454A87Q35752105-3E90D3EF-BADF-4495-9E59-0F4ADCB34314Q36012974-F7426EFB-49FF-4343-9C4D-4EB6DBE13FCDQ36070579-ADE7A019-A39F-4CDA-969A-33726207CFAFQ36770573-CF34E8CA-BB12-4EC5-83B6-C20B0CCE29B0Q36771109-55D4CF60-440B-4FB7-B515-2C6CEAB9606DQ36787669-882241D7-F71F-41F3-A949-0190A4107531Q37157185-7949C21C-993D-4A19-B762-5D10BC66C6AFQ37197930-76B5A10E-2343-42DB-9F77-5B14E558A9C7Q37630472-169273ED-3341-4672-8B28-C796AE2EAB52Q38080418-BE804E1B-6D6D-4F3E-BDEC-46BAA6B77CA0Q38232022-567215D4-AD22-4F74-B40E-55F5C52169EFQ38289100-E993CFA7-A522-4327-9EC6-CD7E4C0B4B4CQ38483116-64DB126B-754B-4586-983C-A4981B89E04AQ38652442-6FFE5A88-7E58-468A-85CF-8A640452A3E2Q39600741-CD154466-7F3E-4CA6-B1FA-993B895A27A9Q39806167-A84A0119-9BAF-4067-BCB2-A5FBDD1B84B6Q42358786-20A394B1-06DC-46E2-805E-8CAB3F741451Q42546666-A503D270-4517-4F78-B59F-53D3130682F5Q47400920-A36F0161-5B86-4D92-93E0-784680F0D8FFQ47764181-1AB13C19-90EB-4866-A734-6D1F9D632F2AQ49968034-5384B64A-6A44-492D-B7F4-3E4F4EC09D9DQ52891441-22260DC5-D177-4C4A-BE64-82091DEF851B
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Evolution of cyclic peptide protease inhibitors.
@ast
Evolution of cyclic peptide protease inhibitors.
@en
type
label
Evolution of cyclic peptide protease inhibitors.
@ast
Evolution of cyclic peptide protease inhibitors.
@en
prefLabel
Evolution of cyclic peptide protease inhibitors.
@ast
Evolution of cyclic peptide protease inhibitors.
@en
P2093
P2860
P356
P1476
Evolution of cyclic peptide protease inhibitors.
@en
P2093
Douglas D Young
Insha Ahmad
John M Louis
Peter G Schultz
Stephen J Benkovic
Travis S Young
P2860
P304
11052-11056
P356
10.1073/PNAS.1108045108
P407
P577
2011-06-20T00:00:00Z